Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors
Clinical trial NCT03447314 · COMPLETED
Trial details
- NCT number
- NCT03447314
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-26
- Primary completion
- 2020-07-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.